SUMMARY  

• Johnson & Johnson cannot recommend any practices, procedures, or dosage administration techniques that deviate from the approved product labeling.
• ERLEADA 240 mg is not commercially available as a solution or suspension.
• For patients with a feeding tube, the ERLEADA 240 mg tablet can be administered through a feeding tube 8 French or greater.¹
• Results from in vitro studies to evaluate compatibility of 1 dispersed 240 mg tablet administered via nasogastric (NG) tubes of ≥8 French diameter made of polyurethane, silicone, or polyvinyl chloride have been published.²

ALTERNATE METHOD OF ADMINISTRATION

Administer 240 mg Tablet Through a Feeding Tube

ERLEADA 240 mg tablet can be administered through a feeding tube 8 French or greater as follows¹:

1. Place one 240 mg tablet in the barrel of the syringe (use at least a 20 mL syringe) and draw up 10 mL of non-carbonated water into the syringe.
2. Wait 10 minutes and then shake vigorously to disperse contents completely.
3. Administer immediately through the feeding tube.
4. Refill the syringe with non-carbonated water and administer. Repeat until no tablet residue is left in the syringe or feeding tube.

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File (and/or other resources, including internal/external databases) was conducted on 10 July 2024.